Search Results - "Gunduz, Mithat"

Refine Results
  1. 1

    In vitro ocular metabolism and bioactivation of ketoconazole in rat, rabbit and human by Cirello, Amanda L., Dumouchel, Jennifer L., Gunduz, Mithat, Dunne, Christine E., Argikar, Upendra A.

    Published in Drug metabolism and pharmacokinetics (01-04-2017)
    “…Oral ketoconazole is clinically administered for treatment of severe cases for fungal keratitis. Pharmacodynamics and efficacy of oral and topical (ocular)…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Comprehensive Assessment of Human Pharmacokinetic Prediction Based on In Vivo Animal Pharmacokinetic Data, Part 2: Clearance by Lombardo, Franco, Waters, Nigel J., Argikar, Upendra A., Dennehy, Michelle K., Zhan, Jenny, Gunduz, Mithat, Harriman, Shawn P., Berellini, Giuliano, Liric Rajlic, Ivana, Obach, R. Scott

    Published in Journal of clinical pharmacology (01-02-2013)
    “…A comprehensive analysis on the prediction of human clearance based on intravenous pharmacokinetic data from rat, dog, and monkey for approximately 400…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Using a Tritiated Compound to Elucidate Its Preclinical Metabolic and Excretory Pathways in Vivo: Exploring Tritium Exchange Risk by SHAFFER, Christopher L, GUNDUZ, Mithat, THORNBURGH, Bruce A, FATE, Gwendolyn D

    Published in Drug metabolism and disposition (01-09-2006)
    “…The metabolism and excretion of N -(3 R )-1-azabicyclo[2.2.2]oct-3-ylfuro[2,3- c ]pyridine-5-carboxamide (1), an agonist of the α 7 nicotinic…”
    Get full text
    Journal Article
  6. 6

    New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation by Gunduz, Mithat, Argikar, Upendra A, Cirello, Amanda L, Dumouchel, Jennifer L

    Published in Drug metabolism letters (2018)
    “…Acyl glucuronides of xenobiotics have been a subject of wide interest from the pharmaceutical industry with respect to biochemical reactivity, hepatic…”
    Get more information
    Journal Article
  7. 7

    BIOTRANSFORMATION OF A GABAA RECEPTOR PARTIAL AGONIST IN SPRAGUE-DAWLEY RATS AND CYNOMOLGUS MONKEYS: IDENTIFICATION OF TWO UNIQUE N-CARBAMOYL METABOLITES by SHAFFER, Christopher L, GUNDUZ, Mithat, O'CONNELL, Thomas N, OBACH, R. Scott, YEE, Shiyin

    Published in Drug metabolism and disposition (01-11-2005)
    “…The absorption, metabolism, and excretion of N -[3-fluoro-4-[2-(propylamino)ethoxy]phenyl]-4,5,6,7-tetrahydro-4-oxo-1 H -indole-3-carboxamide…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Species-dependent hepatic and intestinal metabolism of selective oestrogen receptor degrader LSZ102 by sulphation and glucuronidation by Pearson, David, Jin, Yi, Romeo, Andrea, Birlinger, Bertrand-Luc, Schiller, Hilmar, Ji, Yan, Gunduz, Mithat, Baldoni, Daniela, Walles, Markus

    Published in Xenobiotica (02-01-2022)
    “…LSZ102 is an orally bioavailable selective oestrogen receptor degrader in clinical development for the treatment of breast cancer. Preclinical studies showed…”
    Get full text
    Journal Article
  11. 11

    Models and Approaches Describing the Metabolism, Transport, and Toxicity of Drugs Administered by the Ocular Route by Dumouchel, Jennifer L, Chemuturi, Nagendra, Milton, Mark N, Camenisch, Gian, Chastain, James, Walles, Markus, Sasseville, Vito, Gunduz, Mithat, Iyer, Ganesh R, Argikar, Upendra A

    Published in Drug metabolism and disposition (01-11-2018)
    “…The eye is a complex organ with a series of anatomic barriers that provide protection from physical and chemical injury while maintaining homeostasis and…”
    Get full text
    Journal Article
  12. 12

    Do We Need to Study Metabolism and Distribution in the Eye: Why, When, and Are We There Yet? by Argikar, Upendra A, Dumouchel, Jennifer L, Kramlinger, Valerie M, Cirello, Amanda L, Gunduz, Mithat, Dunne, Christine E, Sohal, Bindi

    Published in Journal of pharmaceutical sciences (01-09-2017)
    “…The liver is known to be the principal site of drug metabolism. Depending on the route of administration, especially in cases of topical and local delivery,…”
    Get more information
    Journal Article
  13. 13

    Ocular Metabolism of Levobunolol: Historic and Emerging Metabolic Pathways by Argikar, Upendra A, Dumouchel, Jennifer L, Dunne, Christine E, Saran, Chitra, Cirello, Amanda L, Gunduz, Mithat

    Published in Drug metabolism and disposition (01-08-2016)
    “…Although ocular transport and delivery have been well studied, metabolism in the eye is not well documented, even for clinically available medications such as…”
    Get full text
    Journal Article
  14. 14

    Identification of a Novel N-Carbamoyl Glucuronide: In Vitro, In Vivo, and Mechanistic Studies by GUNDUZ, Mithat, ARGIKAR, Upendra A, BAESCHLIN, Daniel, FERREIRA, Suzie, HOSAGRAHARA, Vinayak, HARRIMAN, Shawn

    Published in Drug metabolism and disposition (01-03-2010)
    “…1-[4-Aminomethyl-4-(3-chlorophenyl)-cyclohexyl]-tetrahydro-pyrimidin- 2-one, 1, was developed as an inhibitor of dipeptidyl peptidase-4 enzyme…”
    Get full text
    Journal Article
  15. 15

    Oxidative ipso substitution of 2,4-difluoro-benzylphthalazines: identification of a rare stable quinone methide and subsequent GSH conjugate by Gunduz, Mithat, Argikar, Upendra A, Kamel, Amin, Colizza, Kevin, Bushee, Jennifer L, Cirello, Amanda, Lombardo, Franco, Harriman, Shawn

    Published in Drug metabolism and disposition (01-11-2012)
    “…In vitro metabolite identification and GSH trapping studies in human liver microsomes were conducted to understand the bioactivation potential of compound 1…”
    Get full text
    Journal Article
  16. 16

    In vitro-in vivo correlation for intrinsic clearance for CP-409,092 and sumatriptan: a case study to predict the in vivo clearance for compounds metabolized by monoamine oxidase by Kamel, Amin, Colizza, Kevin, Gunduz, Mithat, Harriman, Shawn, Obach, R. Scott

    Published in Xenobiotica (01-04-2012)
    “…Oxidative deamination of the GABAA partial agonist CP-409,092 and sumatriptan represents a major metabolic pathway and seems to play an important role for the…”
    Get full text
    Journal Article
  17. 17

    Metabolism and disposition of a selective alpha(7) nicotinic acetylcholine receptor agonist in humans by Shaffer, Christopher L, Gunduz, Mithat, Scialis, Renato J, Fang, Annie F

    Published in Drug metabolism and disposition (01-07-2007)
    “…The metabolism and disposition of N-(3R)-1-azabicyclo[2.2.2]oct-3-ylfuro[2,3-c]pyridine-5-carboxamide (1), an alpha(7) nicotinic acetylcholinergic receptor…”
    Get full text
    Journal Article
  18. 18

    Species Differences in the Biotransformation of an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist: The Effects of Distinct Glucuronide Metabolites on Overall Compound Disposition by Christopher L. Shaffer, Mithat Gunduz, Tim F. Ryder, Thomas N. O'Connell

    Published in Drug metabolism and disposition (01-02-2010)
    “…The metabolism and disposition of (1 R ,5 S )-2,3,4,5-tetrahydro-7-(trifluoromethyl)-1,5-methano-1 H -3-benzazepine (1), an α 4 β 2 nicotinic acetylcholine…”
    Get full text
    Journal Article
  19. 19
  20. 20